What Is NEMT Transportation and Who Qualifies?

Non-emergency medical transportation, usually called NEMT, is a benefit that covers rides to and from medical appointments that do not require an ambulance. Every state Medicaid program is federally required to provide it, making Medicaid enrollees the largest group of people who qualify. Beyond Medicaid, a growing share of Medicare Advantage plans now offer NEMT as a supplemental benefit, and some private insurers and Veterans Affairs programs cover it as well. Despite being a mandated Medicaid benefit, fewer than one in twenty Medicaid beneficiaries actually used NEMT in 2018, pointing to a gap between who qualifies on paper and who gets rides in practice.

How Medicaid NEMT Works

Federal law requires that state Medicaid programs ensure beneficiaries can get to covered medical services. In practice, this means that if you are enrolled in Medicaid and lack reliable transportation to a doctor’s office, clinic, hospital, pharmacy, or other covered provider, your state must arrange a way to get you there. The ride itself is free to the beneficiary, though the specifics of how it is arranged vary widely by state.

In many states, the responsibility for coordinating rides has shifted from local government offices to private transportation brokers. North Carolina offers a clear example: before its Medicaid transformation, county Departments of Social Services relied on community transit organizations to coordinate NEMT. After the shift, private brokers took over deciding eligibility, selecting transportation providers, and scheduling rides. In 2019, community transit organizations in North Carolina provided 1.3 million NEMT rides, representing roughly a quarter of all transit trips in the state and about a fifth of transit revenues.

To use NEMT through Medicaid, you typically need to call a broker or your managed care plan ahead of time, explain that you have a medical appointment, and confirm you have no other way to get there. The broker then assigns a vehicle and driver. Some states require a certain number of hours or days of advance notice. The process can feel bureaucratic, and wait times, scheduling confusion, and long ride times are common complaints, but the service itself costs the rider nothing.

Why So Few People Use a Benefit They Already Have

One of the most striking findings in the research is how few Medicaid enrollees even know they have access to NEMT. A study of Iowa Medicaid enrollees found that only about a quarter of expansion members with NEMT coverage were accurately aware their plan included transportation to non-emergency visits. Among traditional Medicaid members, the number was even lower: just 19% knew the benefit existed. For expansion members who did not have the NEMT benefit, 84% were either unsure or mistakenly believed they did have it.

Usage rates reflect this confusion. Among expansion members who had the benefit, only 9% reported using it in the past six months. For traditional Medicaid members, that figure dropped to 3%.

Nationally, a mandated report found that less than 5% of Medicaid beneficiaries used NEMT benefits in 2018 despite the coverage being universal across states.

The gap is not just about people forgetting a benefit exists. Many enrollees receive little or no education about what their Medicaid coverage includes beyond doctor visits and prescriptions. Others may have tried the service once, had a bad experience with long wait times or missed pickups, and decided it was easier to skip the appointment or find another way. For people with chronic conditions who need regular visits, that pattern of skipped care adds up fast.

Medicare Advantage and Expanding Coverage

Medicaid has long been the main vehicle for NEMT, but Medicare Advantage plans have been adding it as a supplemental benefit at a rapid pace. In 2020, about 27% of MA plans offered some form of NEMT. By 2023, that figure had climbed to nearly 47%. The number dipped slightly to about 41% in 2024, but the overall trajectory over those five years was a clear upward trend.

⁴

The availability of NEMT in Medicare Advantage is not evenly distributed. Counties with the greatest transportation barriers are more likely to have MA plans offering NEMT, which makes intuitive sense: insurers in areas where patients struggle to reach appointments have a financial incentive to solve the problem. In 2024, there was roughly a 19-percentage-point gap in NEMT availability between counties with the fewest transportation barriers and those with the most.

⁴

Within Medicare Advantage, a newer category called Value-Based Insurance Design (VBID) plans tends to be more generous with NEMT than traditional MA plans. All VBID plans in one recent analysis offered NEMT, compared to about 45% of traditional MA plans. VBID plans were also less likely to require copays, more likely to offer unlimited trips, and less likely to restrict rides to only certain types of health care locations.

⁵

If you are enrolled in a Medicare Advantage plan and are unsure whether NEMT is included, the simplest route is to check your plan’s Evidence of Coverage document or call the member services number on your insurance card. Unlike Medicaid, Medicare Advantage NEMT is not federally mandated. It is an optional supplemental benefit, so coverage varies by plan and by year.

What NEMT Rides Actually Look Like

NEMT is not a single type of vehicle. The ride you get depends on your medical condition, mobility level, and what your plan or broker authorizes. Common NEMT modes include sedan cars, wheelchair-accessible vans, stretcher vans for people who cannot sit upright, and public transit passes or vouchers. In some states, mileage reimbursement for a friend or family member who drives you is also an option.

Wheelchair and stretcher vans are the most specialized tier. In Shanghai, for instance, NEMT is formally defined as trips from medical institutions to non-medical destinations requiring special vehicles, and the vehicles themselves are typically wheelchair- or stretcher-carrying vans similar to those used in Australia.

⁶

In the United States, the vehicle assigned usually comes down to what the broker determines you need. If you can sit in a regular car, you get a sedan. If you use a wheelchair, you get a wheelchair-accessible vehicle. If you are being discharged from a hospital and cannot sit upright, you may get a stretcher van. Ambulances are reserved for emergencies and are a separate category entirely.

More recently, rideshare companies have entered the NEMT space. Some paratransit providers have partnered with rideshare platforms, citing the increased flexibility and reliability that on-demand ride-hailing can offer compared to traditional scheduled paratransit service.

⁷

Does NEMT Actually Reduce Missed Appointments?

The whole premise of NEMT is that giving people rides to the doctor prevents them from missing care. The research broadly supports this, but with some important caveats. A systematic review and meta-analysis that pooled seven studies measuring missed appointments found that NEMT-type interventions cut the odds of a missed appointment by about 37%.

⁸

That pooled result sounds encouraging, but individual studies have been more mixed. One clinical trial that offered rideshare-based transportation to patients with upcoming primary care appointments found essentially no difference in missed appointment rates: about 36.5% in the group offered rides versus 36.7% in the control group. The trial also found no difference in emergency department visits within 7 or 30 days.

⁹

Why the discrepancy? One likely reason is that not everyone who misses an appointment does so because of transportation. Forgetfulness, feeling too sick, work conflicts, childcare, and ambivalence about medical care all contribute. Offering a ride only helps the subset of people whose primary barrier is actually getting there. A pilot program at a primary care practice serving Medicaid patients told a more encouraging story: at the practice where rideshare-based transportation was introduced, the show rate improved from 54% to 68%, while the control practice saw its show rate decline from 60% to 51%. After adjusting for patient demographics and provider type, patients at the rideshare practice were about 2.6 times more likely to show up compared to the control.

¹⁰

The evidence is stronger when the intervention is targeted at people who have already identified transportation as their problem, and weaker when rides are offered broadly to all patients regardless of whether transportation was their barrier in the first place. This matters for how NEMT programs are designed: blanket offerings cost more and show smaller effects than targeted ones.

The Economic Case for NEMT

Even when the appointment-show-rate picture is complicated, the economic argument for NEMT holds up well. A cost-effectiveness analysis examining 12 common and costly medical conditions found that providing NEMT to people who lacked it produced net cost savings for four conditions: prenatal care, asthma, heart disease, and diabetes. For those four, the money saved in averted emergency care and complications more than offset the cost of the rides.

¹¹

For the remaining eight conditions studied, including cancer screenings, dental care, COPD, hypertension, depression, and end-stage renal disease, NEMT did not produce direct savings but was still cost-effective when factoring in increased life expectancy and improved quality of life. In other words, even where the rides did not pay for themselves dollar-for-dollar, the health improvements they enabled were worth the investment. Across all twelve conditions, the analysis concluded that providing NEMT to people who lack it yields net societal benefits.

¹¹

Rural Areas and the Distance Problem

NEMT faces its stiffest challenges in rural communities. Providers are farther apart, public transit is sparse or nonexistent, and the aging populations in many rural areas have the highest need for medical transportation. In rural Michigan, for example, aging residents struggle to access routine medical care that is often available only at significant distances, compounded by provider shortages and limited local health system resources.

¹²

For a broker-based NEMT system, rural areas present a logistics headache. Finding a qualified driver and vehicle to cover a 45-minute one-way trip for a single passenger is far more expensive per ride than batching multiple urban passengers into overlapping routes. Many rural NEMT trips involve long deadhead miles where the vehicle is empty in one direction. The result is that rural beneficiaries sometimes face longer wait times, narrower scheduling windows, or fewer available rides than their urban counterparts, even though their need is objectively greater.

When Frequent Rides Are a Medical Necessity

The stakes of NEMT are highest for people with conditions requiring regular, recurring treatment. Hemodialysis is the clearest example: patients typically need to reach a dialysis center three times a week, every week. Missing sessions is directly dangerous. A retrospective study of hemodialysis patients found that those relying on Medicaid NEMT, paratransit, or public transit were significantly more likely to miss treatments than those with a private ride. The gap was largest when looking specifically at missed sessions attributed to transportation: Medicaid NEMT users were roughly 2.8 times as likely, and public transit users about 2.7 times as likely, to miss a session for transportation reasons compared to patients with private rides.

¹³

These numbers are sobering because they suggest that having NEMT coverage is not the same as having reliable transportation. The scheduled, broker-coordinated rides that Medicaid provides are better than nothing, but they still fall well short of the reliability a patient gets from a family member or friend who drives them. For dialysis patients in particular, a late or missed pickup can mean a missed treatment window, which can lead to hospitalization or worse.

Cancer survivors face a similar bind. Public health insurance, primarily Medicaid, is common in this group because cancer often causes work limitations and financial hardship. Transportation barriers in the cancer population are tied to increased emergency room use and mortality risk, making NEMT access particularly consequential.

What Makes a Good NEMT Experience

For riders, the quality of the NEMT experience comes down to a few concrete factors. Research examining what drives patient satisfaction with NEMT services found that reliability had the strongest effect on how satisfied riders felt, followed by the technology used for booking and tracking rides, customer service interactions, accessibility of the vehicles, and driver behavior. Among these, accessibility and driver behavior had relatively lower effects on satisfaction, though both still mattered.

¹⁴

Satisfaction, in turn, had a strong positive connection to riders’ sense of well-being. That finding underscores something that policy discussions about NEMT sometimes miss: the ride is not just a logistical problem to be solved. It is an experience that shapes how people feel about their health care, their autonomy, and their day. A ride that shows up on time with a clean vehicle and a courteous driver does more than get someone to a clinic. It communicates that the system works for them, which affects whether they keep scheduling appointments in the future.

Rideshare Partnerships and What They Change

The entry of companies like Lyft and Uber into the NEMT space has generated both optimism and debate. The appeal is obvious: rideshare platforms already have networks of drivers, real-time dispatch technology, and apps that patients can use to track their ride. For plans and brokers, integrating rideshare can reduce the overhead of maintaining dedicated vehicle fleets.

The pilot study that found a 2.6-fold increase in show rates at a Medicaid primary care practice used a rideshare-based model, and the average cost per consenting patient was about $14.

¹⁰ That is a modest per-ride investment, especially if it prevents a downstream emergency room visit. But the clinical trial that found no improvement in missed appointments also used rideshare-based transportation, and the average cost there was similar at about $14 per patient.

⁹

The difference between these two results likely comes back to targeting. The pilot that worked was embedded in a practice that served Medicaid patients who had already been identified as transportation-disadvantaged. The trial that showed no effect offered rides to a broader pool of patients, many of whom may have had other reasons for skipping appointments. Rideshare is a tool, and like any tool, it works best when aimed at the right problem.

There are also populations that rideshare cannot easily serve. Patients who use wheelchairs, need stretcher transport, or require an attendant during the ride still need specialized vehicles. Most rideshare drivers operate standard sedans. Some rideshare platforms have launched wheelchair-accessible vehicle programs in select cities, but coverage remains patchy. For the foreseeable future, rideshare will supplement rather than replace the specialized fleet that NEMT has traditionally relied on.

1
ScienceDirect. Impacts of North Carolina’s medicaid transformation on community transit systems: A qualitative analysis with policy implications
2
Oxford Academic. Transportation barriers for Iowa Medicaid-enrolled adults with and without non-emergency medical transportation services
3
Oxford Academic (JNCI: Journal of the National Cancer Institute). Transportation barriers, emergency room use, and mortality risk among US adults by cancer history
4
Health Affairs Scholar. Geographic variation in Medicare Advantage nonemergency medical transportation benefits 2020-2024
5
JAMA Network Open. Nonemergency Medical Transportation Benefit in Traditional Medicare Advantage and Value-Based Plans
6
F1000Research. Non-emergency medical transportation practice in Shanghai
7
PubMed Central. Innovative health care mobility services in the US
8
PubMed Central. Effect of interventions for non-emergent medical transportation: a systematic review and meta-analysis
9
JAMA Internal Medicine. Association of Rideshare-Based Transportation Services and Missed Primary Care Appointments: A Clinical Trial
10
PubMed Central. Rideshare-Based Medical Transportation for Medicaid Patients and Primary Care Show Rates: A Difference-in-Difference Analysis of a Pilot Program
11
Transportation Research Record: Journal of the Transportation Research Board. Cost-Effectiveness of Access to Nonemergency Medical Transportation
12
Michigan Journal of Public Health. Deficiencies in Non-Emergency Medical Transportation for Aging Rural Residents of Iosco County, Michigan
13
PubMed Central. Transportation Insecurity and Outcomes in Hemodialysis Patients: A Retrospective Cohort Study
14
Elsevier / Transportation Research Part D: Transport and Environment. How do non-emergency medical transportation services influence patients’ subjective well-being?